|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| 3rd International Conference on Signal Transduction | ||||||||||||||||
| January 29, 2002 | ||||||||||||||||
|
Ruder Boskovic Institute, Dubrovnik, Croatia May 17-23, 2002 May 17- arrival, 7-11 p.m. welcoming reception May 18, 2002 Protein phosphorylation Joseph Schlessinger, Yale University, USA Tony Hunter, Salk Institute, USA Tony Pawson, Samuel Lunenfeld Research Institute, Canada Michael Karin, University of California San Diego, USA GTPases and MAP kinases Dafna Bar-Sagi, SUNY, USA Chris Marshall, Institute of Cancer Research, UK Silvio Gutkind, NIH, USA Melanie Cobb, University of Texas, USA May 19, 2002 Protein posttranslational modifications Yosef Yarden, Weizmann Institute, Israel Pier Paolo Di Fiore, European Institute of Oncology, Italy Stefan Jentsch, Max Planck Institute, Germany Stephen Cohen, EMBL, Germany Wallace Langdon, University of Western Australia, Australia Keynote lecture: Guenter Blöbel, Rockefeller University, USA Nuclear signaling Thomas Perlmann, Ludwig Institute for Cancer Research, Sweden Hans Clevers, Utrecht University, Holland May 20, 2002 Functional Genomics and Proteomics Michael Waterfield, Ludwig Institute for Cancer Research, UK Lewis Cantley, Harvard Medical School, USA Wilhelm Ansorge, EMBL, Germany Julio Celis, Danish Centre for Human Genome Research, Denmark Live Imaging Benjamin Geiger, Weizmann Institute, Israel Philippe Bastiaens, EMBL, Germany Neuroscience Patricia Goldman-Rakic, Yale University, USA Jean-Pierre Changeux, Pasteur Institute, France May 21, 2002 Development and Disease Inder Werma, Salk Institute, USA Ronald Kahn, Joslin Diabetes Center, USA Christer Betsholtz, Gottenburg University, Sweden Kari Alitalo, Haartman Institute, Finland Immunology Klaus Rajewsky, Harvard University, USA James Ihle, St. Jude Hospital, USA Arthur Weiss, University of California San Francisco, USA Zlatko Dembic, Oslo University, Norway May 22, 2002 Trip to the island Mljet Farewell party May 23, 2002 – departure |
||||||||||||||||
| Organized by: | I. Dikic, K. Pavelic, J. Schlessinger | |||||||||||||||
| Invited Speakers: | Guenter Blöbel, Rockefeller University, USA Joseph Schlessinger, Yale University, USA Tony Hunter, Salk Institute, USA Tony Pawson, Samuel Lunenfeld Research Institute, Canada Micahel Karin, UCSD, USA Dafna Bar-Sagi, SUNY, USA Chris Marshall, Institute of Cancer Research, UK Silvio Gutkind, NIH, USA Melanie Cobb, University of Texas, USA Yosef Yarden, Weizmann Institute, Israel Pier Paolo Di Fiore, European Institute of Oncology, Italy Stefan Jentsch, Max Planck Institute, Germany Stephen Cohen, EMBL, Germany Wallace Langdon, University of Western Australia, Australia Michael Waterfield, Ludwig Institute for Cancer Research, UK Lewis Cantley, Harvard Medical School, USA Wilhelm Ansorge, EMBL, Germany Julio Celis, Danish Centre for Human Genome Research, Denmark Thomas Perlmann, Ludwig Institute for Cancer Research, Sweden Hans Clevers, Utrecht University, Holland Inder Werma, Salk Institute, USA Ronald Kahn, Joslin Diabetes Center, USA Christer Betsholtz, Gottenburg University, Sweden Kari Alitalo, Haartman Institute, Finland Klaus Rajewsky, Harvard University, USA James Ihle, St. Jude Hospital, USA Zlatko Dembic, Oslo University, Norway Patricia Goldman-Rakic, Yale University, USA Jean-Pierre Changeux, Pasteur Institute, France Benjamin Geiger, Weizmann Institute, Israel Philippe Bastiaens, EMBL, Germany |
|||||||||||||||
| Deadline for Abstracts: | March 15, 2002 | |||||||||||||||
| Registration: | All info on http://www.icst.irb.hr | |||||||||||||||
| E-mail: | icst@rudjer.irb.hr | |||||||||||||||
| Posted by: | Ivan Dikic | |||||||||||||||
| Host: | ludwig13.ludwig.uu.se | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||